KIKUBO CO.,LTD – Trademark Portfolio
Entity Type: 16
KIKUBO CO.,LTD has 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include LOMLPLUS. The portfolio includes 2 registered trademarks and 1 pending application. Filings span 4 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 5 (Pharmaceuticals). This trademark owner is based in SEOUL CITY.
E908, DANGSAN ROAD 41GIL 11,
YEONGDUNGPO, GU
SEOUL CITY 07217 , KR
Showing of trademarks Trademarks
Trademark Classifications
KIKUBO CO.,LTD's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does KIKUBO CO.,LTD have?
KIKUBO CO.,LTD has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 5 abandoned.
What trademark classes does KIKUBO CO.,LTD file in?
KIKUBO CO.,LTD files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 29 (Meats & Processed Foods). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are KIKUBO CO.,LTD's most well-known trademarks?
KIKUBO CO.,LTD's registered trademark portfolio includes well-known marks such as LOMLPLUS. These are among 2 currently registered trademarks in the portfolio.
What is KIKUBO CO.,LTD's trademark registration success rate?
KIKUBO CO.,LTD has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 1 application is pending review.